Corbevax cleared as Covid booster dose, can be clubbed with other jabs

The DCGI recommended in April that Biological E's Covid-19 vaccine Corbevax be given emergency use authorization for children aged 5 to 12.

Digital Desk: Corbevax, a Covid-19 vaccine developed by Biological E Limited, has been approved by the Drug Controller General of India (DCGI) as a heterologous Covid-19 booster dose. This means that adults who have received their full Covishield or Covaxin vaccination can receive Corbevax as a third or booster shot.

The Corbevax booster can be administered six months after the second dose of the vaccine has been given.

Until now, the booster dosage had to be the same vaccine administered in the first and second shots.

In our Covid-19 vaccination milestone, we've reached another milestone. Corbevax's continued world-class safety standards and e xcellent immunogenicity are reflected in this clearance." Mahima Datla, Managing Director of Hyderabad-based pharmaceutical and Vaccines Company Biological E Ltd, said, "We are really happy with this approval, which will meet the requirement for Covid-19 booster doses in India."

Trials of the Vaccine 

Biological E Ltd recently submitted its clinical trial data to the DCGI, which approved administering Corbevax vaccine as a heterologous booster dose to people who have already received two doses of either Covishield or Covaxin after a thorough review and deliberation with the subject expert committee.

The clinical trial results demonstrated that the Corbevax booster dose improved immune response while remaining safe. Moreover, the company tested 416 people ranging in age from 18 to 80 years old.

This is how you can book a slot to get vaccinated 

A slot to get vaccinated with Corbevax can be booked via the CoWIN portal.

It may be mentioned that so far, at least 51.7 million doses of Corbevax have been administered to children in India, including 17.4 million who have received both doses, Biological E Ltd said. 

The DCGI recommended in April that Biological E's Covid-19 vaccine Corbevax be given emergency use authorization for children aged 5 to 12.